Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.4.1567

Mortality of Major Cancers in Guangxi, China: Sex, Age and Geographical Differences from 1971 and 2005  

Deng, Wei (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Long, Long (Department of Computer Science and Information Technology, Guangxi Teachers Education University)
Li, Ji-Lin (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Zheng, Dan (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Yu, Jia-Hua (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Zhang, Chun-Yan (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Li, Ke-Zhi (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Liu, Hai-Zhou (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Huang, Tian-Ren (Department of Epidemiology, Guangxi Cancer Institute, Guangxi Teachers Education University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.4, 2014 , pp. 1567-1574 More about this Journal
Abstract
The incidence and mortality rates of liver and nasopharyngeal cancer in Guangxi province of China have always been among the highest in the world, and cancer is one of the major diseases that pose a threat to the health of residents in Guangxi. However, no systematic study has been performed to evaluate the time trends in the structure of cancer-related deaths and cancer mortality. In this study, we reveal sex, age and geography differences of cancers mortality between three death surveys (1971 to 1973, 1990 to 1992, and 2004 to 2005). The results show that the standardized mortality rate of cancer in Guangxi residents has risen from 43.3/100,000 to 84.2/100,000, the share of cancer deaths in all-cause deaths has increased from 13.3% to 20.7%, and cancer has become the second most common cause of death. The five major cancers, liver cancer, lung cancer, gastric cancer, nasopharyngeal cancer and colorectal cancer, account for 60% of all the cancer deaths. Cancers with growing mortality rates over the past 30 years include lung cancer, colorectal cancer, liver cancer and female breast cancer, of which lung cancer is associated with the sharpest rise in mortality, with a more than 600% rise in both men and women. Cancer death in Guangxi residents occurs mainly in the elderly population above 45 years of age, especially in people over the age of 65. The areas with the highest mortality rates for liver cancer and nasopharyngeal cancer, which feature regional high incidences, include Chongzuo and Wuzhou. Therefore, for major cancers such as liver cancer, lung cancer, gastric cancer, nasopharyngeal cancer and female breast cancer in Guangxi, we can select high-risk age groups as the target population for cancer prevention and control efforts in high-prevalence areas in a bid to achieve the ultimate goal of lowering cancer mortality in Guangxi.
Keywords
Cancer; mortality; Guangxi; China; 1971-2005;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Turner P, Sylla A, Gong Y, et al (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet, 365, 1950-56.   DOI   ScienceOn
2 World Health Organization (2009). WHO Vaccine-Preventable Diseases: Monitoring System: 2009 Global Summary.
3 Yao H, Shi L. (2003). Meta-analysis of the risk factors on lung cancer in Chinese people. Chinese J Epidemiology, 24, 45-9.
4 He J, Chen WQ (2010). Annual Report of Cancer Registration in China. Beijing: Military Medical Science Press 2012, 10.
5 Ferrari P, Jenab M, Norat T, et al (2007). Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 121, 2065-72.   DOI   ScienceOn
6 Garcia-Alvarez A, Serra-Majem L, Ribas-Barba L, et al (2007). Obesity and overweight trends in Catalonia, Spain (1992- 2003): gender and socio-economic determinants. Public Health Nutr, 10, 1368-78.
7 Gwack J, Park SK, Lee E-H, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12 2205-8.
8 Hulka BS, Moorman PG. (2008). Reprint of Breast cancer: hormones and other risk factors. Maturitas, 61, 203-13.   DOI   ScienceOn
9 Ito K, Tsunematsu M, Satoh K, et al (2013). Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry. Asian Pac J Cancer Prev, 14, 4897-902.   DOI   ScienceOn
10 Kushi LH, Byers T, Doyle C, et al (2006). American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 56, 254-81.   DOI   ScienceOn
11 Mandel JS, Bond JH, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med, 328, 1365-71.   DOI   ScienceOn
12 Ming L, Thorgeirsson SS, Gail MH, et al (2002). Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36, 1214-20.   DOI   ScienceOn
13 Colditz GA, Sellers TA, Trapido E. (2005). Epidemiologyidentifying the causes and preventability of cancer? Nat Rev, 6, 75-83.   DOI   ScienceOn
14 Chang MH. (2014). Prevention of Hepatitis B Virus Infection and Liver Cancer. in: Viruses and Human Cancer, Springer, pp. 75-95.
15 Cho E, Kang MH, Choi S, et al (2013). Cost-effectiveness of Korea's national cervical cancer screening program. Asian Pac J Cancer Prev, 14, 4329-34.   DOI   ScienceOn
16 Cucchetti A, Cescon M, Erroi V, Pinna AD. (2013). Costeffectiveness of liver cancer screening. Best Pract Res Clin Gastroenterol, 27, 961-72.   DOI   ScienceOn
17 de Groot P, Munden RF. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am, 50, 863-76.   DOI
18 Dong ZW, Qiao YL, Li LD, et al.. (2009). A report of cancer high incidence scene in China. China Cancer, 1, 4-9.
19 Dong ZW(2002). Prevention and treatment for cancer, a longlasting approach. China Cancer, 11, 2-3.
20 Fan1 J-H, Wang J-B, Jiang Y, et al (2013). Attributable causes of liver cancer mortality and incidence in China. Asian Pac J Cancer Prev, 14, 7251-56.   DOI   ScienceOn
21 Ferlay J, Bray F, Pisani P, Parkin D. (2007). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0, IARCPress, Lyon, 2004. Valero-Malaria in Colombia, 195.
22 Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer, 113, 2221-43.   DOI   ScienceOn
23 Atkin WS, Edwards R, Kralj-Hans I, et al (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet, 375, 1624-33.   DOI   ScienceOn
24 Center MM, Jemal A, Ward E. (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94.   DOI   ScienceOn
25 Moore MA. (2013). Overview of cancer registration research in the Asian Pacific from 2008-2013. Asian Pac J Cancer Prev, 14, 4461-84.   DOI   ScienceOn
26 Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pacific J Cancer Prev, 14, 6227-31.   DOI   ScienceOn
27 Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al (2008). Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med, 149, 659-69.   DOI   ScienceOn
28 Zhao P, Kong LZ (2010). Cancer death report - the third retrospective sampling survey of death causes, China. First edition, Beijing: People's medical publishing house.
29 Zhu YR (2012). Research progress in prevention of major risk factors of liver cancer in Qidong. China Cancer, 21,759-62.
30 Sankaranarayanan R, Nene BM, Shastri SS, et al (2009). HPV screening for cervical cancer in rural India. N Engl J Med, 360, 1385-94.   DOI   ScienceOn
31 Okamoto E. (2013). Cohort analysis of incidence/mortality of liver cancer in japan through logistic curve fitting. Asian Pac J Cancer Prev, 14, 5891-93.   DOI   ScienceOn
32 Zheng RS, Zhang SW, Wu LY, et al (2012). Report of incidence and mortality from china cancer registries in 2008. China Cancer, 1, 1-12.
33 Sherris J, Wittet S, Kleine A, et al (2009). Evidence-based, alternative cervical cancer screening approaches in lowresource settings. Int Perspect Sex Reprod Health, 35, 147-52.   DOI
34 Spitz M, Wu X, Wilkinson A, et al (2006). Cancer of the lung. Cancer Epidemiol Prev, 3, 638-58.
35 Thun MJ, Hannan LM, Adams-Campbell LL, et al (2008). Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5, e185.   DOI   ScienceOn
36 Centers for Disease Control and Prevention (2007). Best Practices for Comprehensive Tobacco Control Programs. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
37 World Health Organization (2010). Framework Convention On Tobacco Control. 2003. Geneva, Switzerland.